Evaluation of Optimal Sequential Treatment Patterns and Clinical Outcomes in Patients With Advanced Urothelial Carcinoma Treated With First‐Line Platinum‐Based Chemotherapy: A Multicenter Collaborative StudyFumihiko Urabe, Ken Shibata, Masaki Hashimoto et al.|International Journal of Urology|2025Cited by 5
Clinical outcomes and treatment patterns of maintenance avelumab in locally advanced or metastatic urothelial carcinoma: a multicenter collaborative studyFumihiko Urabe, Naoki Uchida, Soshi Kadena et al.|Japanese Journal of Clinical Oncology|2025Cited by 2
Novel Preoperative Immune Prognostic Index for Predicting Outcomes in Patients Undergoing Radical Nephroureterectomy for Upper Tract Urothelial CarcinomaKen Shibata, Fumihiko Urabe, Kosuke Iwatani et al.|In Vivo|2025Cited by 1
Delayed-onset immune-related colitis more than three years after nivolumab therapy for metastatic renal cell carcinoma: A case reportKen Shibata, Takahiro Kimura, Fumihiko Urabe et al.|International Cancer Conference Journal|2025Cited by 1